{"id":"https://openalex.org/W2019223575","doi":"https://doi.org/10.1159/000371497","title":"Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy","display_name":"Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2019223575","doi":"https://doi.org/10.1159/000371497","mag":"2019223575","pmid":"https://pubmed.ncbi.nlm.nih.gov/25591469"},"language":"en","primary_location":{"id":"doi:10.1159/000371497","doi":"https://doi.org/10.1159/000371497","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000371497","pdf_url":null,"source":{"id":"https://openalex.org/S106979888","display_name":"American Journal of Nephrology","issn_l":"0250-8095","issn":["0250-8095","1421-9670"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040062593","display_name":"Luis Miguel Ruilope","orcid":"https://orcid.org/0000-0001-6278-7951","observed_orcids":["https://orcid.org/0000-0001-6278-7951","https://orcid.org/0000-0001-6959-6015"]},"institutions":[{"id":"https://openalex.org/I4210086614","display_name":"Research Institute Hospital 12 de Octubre","ror":"https://ror.org/002x1sg85","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210086614"]},{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Luis M. Ruilope","raw_affiliation_strings":["Institute of Investigation and Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Investigation and Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain","institution_ids":["https://openalex.org/I4210086614","https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089305017","display_name":"Rajiv Agarwal","orcid":"https://orcid.org/0000-0001-8355-7100","observed_orcids":["https://orcid.org/0000-0001-8355-7100","https://orcid.org/0000-0002-3146-7231"]},"institutions":[{"id":"https://openalex.org/I4210110049","display_name":"Richard L. Roudebush VA Medical Center","ror":"https://ror.org/01zpmbk67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110049","https://openalex.org/I4210127612","https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajiv Agarwal","raw_affiliation_strings":["Richard L. Roudebush VA Medical Center, Indianapolis, Ind., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Richard L. Roudebush VA Medical Center, Indianapolis, Ind., USA","institution_ids":["https://openalex.org/I4210110049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091832416","display_name":"Juliana C.N. Chan","orcid":"https://orcid.org/0000-0003-1325-1194","observed_orcids":["https://orcid.org/0000-0003-1325-1194"]},"institutions":[{"id":"https://openalex.org/I177725633","display_name":"Chinese University of Hong Kong","ror":"https://ror.org/00t33hh48","country_code":"HK","type":"education","lineage":["https://openalex.org/I177725633"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Juliana C. Chan","raw_affiliation_strings":["Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China","institution_ids":["https://openalex.org/I177725633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062670268","display_name":"Mark Emmanuel Cooper","orcid":"https://orcid.org/0000-0001-7785-2488","observed_orcids":["https://orcid.org/0000-0001-7785-2488"]},"institutions":[{"id":"https://openalex.org/I142471025","display_name":"Baker Heart and Diabetes Institute","ror":"https://ror.org/03rke0285","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I142471025"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mark E. Cooper","raw_affiliation_strings":["Baker IDI Heart and Diabetes Institute, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baker IDI Heart and Diabetes Institute, Melbourne, Australia","institution_ids":["https://openalex.org/I142471025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005549802","display_name":"Ron T. Gansevoort","orcid":"https://orcid.org/0000-0002-3223-0906","observed_orcids":["https://orcid.org/0000-0002-3223-0906"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ron T. Gansevoort","raw_affiliation_strings":["Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110143117","display_name":"Hermann G. Haller","orcid":"https://orcid.org/0000-0002-8361-6446","observed_orcids":["https://orcid.org/0000-0002-8361-6446","https://orcid.org/0009-0000-5740-838X"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hermann Haller","raw_affiliation_strings":["Departments of Nephrology and Hypertension, Hannover Medical School, Hannover,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Nephrology and Hypertension, Hannover Medical School, Hannover,","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023556434","display_name":"Giuseppe Remuzzi","orcid":"https://orcid.org/0000-0002-6194-3446","observed_orcids":["https://orcid.org/0000-0002-6194-3446"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210106645","display_name":"Ospedale Papa Giovanni XXIII","ror":"https://ror.org/01savtv33","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210106645"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Remuzzi","raw_affiliation_strings":["IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases \u2018Aldo e Cele Dacc\u00f2', Ranica (Bergamo), and","Unit of Nephrology and Dialysis, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases \u2018Aldo e Cele Dacc\u00f2', Ranica (Bergamo), and","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Unit of Nephrology and Dialysis, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy","institution_ids":["https://openalex.org/I4210106645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085592050","display_name":"Peter R Rossing","orcid":"https://orcid.org/0000-0002-1531-4294","observed_orcids":["https://orcid.org/0000-0002-1531-4294","https://orcid.org/0009-0004-5073-0009"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Rossing","raw_affiliation_strings":["Steno Diabetes Center, Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049235067","display_name":"Roland Erich Schmieder","orcid":"https://orcid.org/0000-0003-2356-5883","observed_orcids":["https://orcid.org/0000-0003-2356-5883"]},"institutions":[{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Roland E. Schmieder","raw_affiliation_strings":["Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen,","institution_ids":["https://openalex.org/I4210088053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000418035","display_name":"Christina Nowack","orcid":"https://orcid.org/0000-0002-4288-636X","observed_orcids":["https://orcid.org/0000-0002-4288-636X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christina Nowack","raw_affiliation_strings":["Global Clinical Development, Bayer HealthCare AG, Leverkusen,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Development, Bayer HealthCare AG, Leverkusen,","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016952262","display_name":"Anna Carolina Galv\u00e3o Ferreira","orcid":"https://orcid.org/0000-0003-4853-694X","observed_orcids":["https://orcid.org/0000-0003-4853-694X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna C. Ferreira","raw_affiliation_strings":["Global Clinical Development, Bayer S.A., Bayer HealthCare, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Development, Bayer S.A., Bayer HealthCare, S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067220785","display_name":"Alexander A. Pieper","orcid":"https://orcid.org/0000-0001-5288-8214","observed_orcids":["https://orcid.org/0000-0001-5288-8214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Pieper","raw_affiliation_strings":["M.A.R.C.O. GmbH & Co. KG, D\u00fcsseldorf, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M.A.R.C.O. GmbH & Co. KG, D\u00fcsseldorf, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078153195","display_name":"Nina Kimmeskamp\u2010Kirschbaum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nina Kimmeskamp-Kirschbaum","raw_affiliation_strings":["Global Research and Development Statistics, Bayer HealthCare AG, Leverkusen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Research and Development Statistics, Bayer HealthCare AG, Leverkusen, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012514694","display_name":"George L. Bakris","orcid":"https://orcid.org/0000-0003-1183-1267","observed_orcids":["https://orcid.org/0000-0003-1183-1267"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George L. Bakris","raw_affiliation_strings":["The University of Chicago Medicine, Chicago, Ill., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago Medicine, Chicago, Ill., USA","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5040062593"],"corresponding_institution_ids":["https://openalex.org/I4210086614","https://openalex.org/I4210101691"],"apc_list":null,"apc_paid":null,"fwci":5.2739,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.95322442,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"40","issue":"6","first_page":"572","last_page":"581"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.925000011920929},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mineralocorticoid-receptor-antagonists","display_name":"mineralocorticoid receptor antagonists","score":0.9279999732971191},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.9670000076293945},{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.906000018119812},{"id":"https://openalex.org/keywords/serum-potassium","display_name":"serum potassium","score":0.9039999842643738},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.859000027179718},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9120357036590576},{"id":"https://openalex.org/C2776174234","wikidata":"https://www.wikidata.org/wiki/Q974792","display_name":"Albuminuria","level":3,"score":0.7295082807540894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6560226082801819},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5235964059829712},{"id":"https://openalex.org/C2781203188","wikidata":"https://www.wikidata.org/wiki/Q1676817","display_name":"Microalbuminuria","level":3,"score":0.5002152919769287},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4844772517681122},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.480214923620224},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.47516483068466187},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.47190243005752563},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4471363425254822},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.41661977767944336},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.37772491574287415},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34815001487731934},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32224535942077637},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08779242634773254},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011188","descriptor_name":"Potassium","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D065627","descriptor_name":"Familial Primary Pulmonary Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D065627","descriptor_name":"Familial Primary Pulmonary Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1159/000371497","doi":"https://doi.org/10.1159/000371497","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000371497","pdf_url":null,"source":{"id":"https://openalex.org/S106979888","display_name":"American Journal of Nephrology","issn_l":"0250-8095","issn":["0250-8095","1421-9670"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Nephrology","raw_type":"journal-article"},{"id":"pmid:25591469","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25591469","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of nephrology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:ub.uni-erlangen.de-opus:10601","doi":null,"is_oa":false,"landing_page_url":"https://opus4.kobv.de/opus4-fau/files/10601/AJN371497.pdf","pdf_url":"https://opus4.kobv.de/opus4-fau/files/10601/AJN371497.pdf","source":{"id":"https://openalex.org/S4306402340","display_name":"OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universit\u00e4tsbibliothek Erlangen-N\u00fcrnberg)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"pmh:oai:aleph.bib-bvb.de:BVB01-030899451","doi":null,"is_oa":false,"landing_page_url":"https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106011","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"software, multimedia"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/16ca09dc-b6c1-4cc5-85a0-3cdabe2af8a9","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/16ca09dc-b6c1-4cc5-85a0-3cdabe2af8a9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/16ca09dc-b6c1-4cc5-85a0-3cdabe2af8a9","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/16ca09dc-b6c1-4cc5-85a0-3cdabe2af8a9","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Journal of Nephrology, 40(6), 572 - 581. KARGER","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1971680322","https://openalex.org/W1998943227","https://openalex.org/W2000812251","https://openalex.org/W2002381859","https://openalex.org/W2010320457","https://openalex.org/W2010799694","https://openalex.org/W2012631324","https://openalex.org/W2017268330","https://openalex.org/W2043578667","https://openalex.org/W2045045479","https://openalex.org/W2071416829","https://openalex.org/W2072543770","https://openalex.org/W2073062706","https://openalex.org/W2079169053","https://openalex.org/W2090526184","https://openalex.org/W2091788165","https://openalex.org/W2099643746","https://openalex.org/W2109209184","https://openalex.org/W2112948259","https://openalex.org/W2116687798","https://openalex.org/W2118932957","https://openalex.org/W2119340816","https://openalex.org/W2125089162","https://openalex.org/W2126887196","https://openalex.org/W2129883332","https://openalex.org/W2132715232","https://openalex.org/W2133731562","https://openalex.org/W2138612646","https://openalex.org/W2138862624","https://openalex.org/W2148910374","https://openalex.org/W2150426711","https://openalex.org/W2152094259","https://openalex.org/W2160407912","https://openalex.org/W2163709605","https://openalex.org/W2164705414","https://openalex.org/W2323458614","https://openalex.org/W4234105576","https://openalex.org/W4234113403","https://openalex.org/W4242364069"],"related_works":["https://openalex.org/W2562375370","https://openalex.org/W1830102405","https://openalex.org/W7213284609","https://openalex.org/W7163023928","https://openalex.org/W4415422411","https://openalex.org/W7152502916","https://openalex.org/W7214680794","https://openalex.org/W4401979895","https://openalex.org/W4402335048","https://openalex.org/W4415474545"],"abstract_inverted_index":{"BACKGROUND/AIMS:":[0],"Finerenone":[1],"decreases":[2],"albuminuria":[3,48,170,175],"in":[4,53,57,110,120,132,209,213,218,232,238],"patients":[5,58,111,148,239],"having":[6],"heart":[7],"failure":[8],"with":[9,59,118,234,240],"reduced":[10],"ejection":[11],"fraction":[12],"and":[13,64,114,137,140,189,215,245],"mild-to-moderate":[14],"(stage":[15],"2-3)":[16],"chronic":[17],"kidney":[18],"disease.":[19],"The":[20,90],"MinerAlocorticoid":[21],"Receptor":[22],"Antagonist":[23],"Tolerability":[24],"Study-Diabetic":[25],"Nephropathy":[26],"(ARTS-DN;":[27],"NCT01874431)":[28],"is":[29,224],"a":[30,65,73,204,235,246],"multicenter,":[31],"randomized,":[32],"double-blind,":[33],"placebo-controlled,":[34],"parallel-group,":[35],"phase":[36,227],"2b":[37,228],"study.":[38],"ARTS-DN":[39,223],"investigated":[40],"whether":[41],"the":[42,96,99,121,225],"mineralocorticoid":[43],"receptor":[44],"antagonist":[45],"finerenone":[46,83,231],"reduces":[47],"without":[49],"causing":[50],"major":[51],"alterations":[52],"serum":[54,133],"potassium":[55,134],"levels":[56],"type":[60,241],"2":[61,242],"diabetes":[62,243],"mellitus":[63,244],"clinical":[66,247],"diagnosis":[67,248],"of":[68,98,143,159,206,220,230,249],"DN":[69],"who":[70],"were":[71,79,93],"receiving":[72,112],"renin-angiotensin-system":[74],"(RAS)":[75],"inhibitor.":[76],"METHODS:":[77],"Patients":[78],"randomized":[80],"to":[81,94,106,115],"oral":[82],"1.25-20":[84],"mg":[85],"or":[86],"placebo":[87,122],"once":[88],"daily.":[89],"primary":[91],"objectives":[92],"assess":[95],"ratio":[97,102],"urinary":[100],"albumin-to-creatinine":[101],"at":[103,108,155],"day":[104],"90":[105],"that":[107,119],"baseline":[109,131],"finerenone,":[113],"compare":[116],"it":[117],"group.":[123],"Additional":[124],"exploratory":[125],"analyses":[126],"included":[127],"evaluating":[128],"changes":[129],"from":[130],"levels,":[135],"efficacy":[136],"safety":[138],"biomarkers,":[139],"health-related":[141],"quality":[142],"life.":[144],"RESULTS:":[145],"Of":[146],"1,501":[147],"screened,":[149],"821":[150],"(the":[151],"sample":[152],"population)":[153],"received":[154],"least":[156],"one":[157],"dose":[158],"finerenone/placebo.":[160],"Baseline":[161],"characteristics":[162],"included:":[163],"male,":[164],"77.8%;":[165],"white,":[166],"84.2%;":[167],"very":[168],"high":[169,174],"(formerly":[171,176],"macroalbuminuria),":[172],"38.4%;":[173],"microalbuminuria),":[177],"60.3%;":[178],"median":[179],"(range)":[180],"estimated":[181],"glomerular":[182],"filtration":[183],"rate,":[184],"66.3":[185],"(24.5-130.7)":[186],"ml/min/1.73":[187],"m(2);":[188],"systolic":[190],"blood":[191],"pressure":[192],"(mean":[193],"\u00b1":[194,198],"standard":[195],"deviation),":[196],"138.1":[197],"14.4":[199],"mm":[200],"Hg.":[201],"There":[202],"was":[203],"history":[205],"cardiovascular":[207],"disease":[208],"39.6%,":[210],"diabetic":[211,216],"neuropathy":[212],"20.0%,":[214],"retinopathy":[217],"19.9%":[219],"patients.":[221],"CONCLUSION:":[222],"first":[226],"trial":[229],"combination":[233],"RAS":[236],"inhibitor":[237],"DN.":[250]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":10}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}